BCAX Enterprise Value
$35.22 M
+$6.90 M+24.38%
Thu, 23 Jan 2025 11:15:51 GMT
Summary:
As of January 23, 2025, BCAX enterprise value is $35.22 million, with a rise of +$6.90 million (+24.38%) during the most recent trading day. BCAX enterprise value is now -96.62% below its all-time high of $1.04 billion.BCAX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +24.4% | +1.3% | +1.3% |
| 1 m1 month | -89.7% | -35.6% | -35.6% |
| 3 m3 months | -93.2% | -46.3% | -46.3% |
| 6 m6 months | - | - | - |
| ytdytd | -87.5% | -30.7% | -30.7% |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
BCAX Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | $360 M | -90.2% | $14 M | +159.2% |
| 3 m | 3-month | $639 M | -94.5% | $14 M | +159.2% |
| 6 m | 6-month | $1.04 B | -96.6% | $14 M | +159.2% |
| 1 y | 1-year | $1.04 B | -96.6% | $14 M | +159.2% |
| 3 y | 3-year | $1.04 B | -96.6% | $14 M | +159.2% |
| 5 y | 5-year | $1.04 B | -96.6% | $14 M | +159.2% |
| alltime | all time | $1.04 B | -96.6% | $14 M | +159.2% |
Bicara Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $35.22 M(-87.5%) |
| Date | Value |
|---|---|
| 2024 | $281.46 M |
FAQ
- What is Bicara Therapeutics enterprise value?
- What is the all time high enterprise value for Bicara Therapeutics?
- What is BCAX enterprise value year-to-date change?
What is Bicara Therapeutics enterprise value?
The current enterprise value of BCAX is $35.22 M
What is the all time high enterprise value for Bicara Therapeutics?
Bicara Therapeutics all-time high enterprise value is $1.04 B
What is BCAX enterprise value year-to-date change?
Bicara Therapeutics enterprise value has changed by -$246.24 M (-87.49%) since the beginning of the year